ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today expanded its healthcare informatics offering via the launch of the enhanced Invacare® Platinum® Mobile Oxygen Concentrator with Connectivity. This is the company’s second application of healthcare informatics following the launch of LiNX® technology on its new Invacare® TDX® SP2 power wheelchair in August 2017.
With the launch of the Platinum Mobile Oxygen Concentrator with Connectivity, the company is bringing new technology to respiratory end users and home medical equipment providers that helps build patient confidence, offers a lightweight portable oxygen solution, and allows the end user and provider to share product data easily and help improve usability.
“We are excited about our emerging platforms in healthcare informatics, which combines information technology and healthcare to develop more efficient and intuitive ways of accessing and analyzing product information. We now have applied informatics to two of our main product lines – oxygen and custom power wheelchairs. Having access to product data helps home medical equipment providers and clinicians more effectively serve the people who use our products, and it helps Invacare understand and develop the next era of innovation,” said Matthew E. Monaghan, chairman, president and chief executive officer.
The enhanced Platinum Mobile with Connectivity features the easy-to-use Piccolo O2 App, allowing end users to view the battery time remaining on their portable oxygen concentrator as well as obtain information and support from their phone screen. In addition, providers will now have access to a dedicated portal that shares information from an integrated system, providing remote visibility to product usage and performance data.
The Invacare Platinum Mobile Oxygen Concentrator with Connectivity is being introduced on October 24, 2017, at Medtrade, the largest home medical equipment trade show and conference, in Atlanta, Georgia. For more information, visit www.Invacare.com/BreatheSmartBreatheEasy.
About Invacare Corporation
Invacare Corporation (NYSE: IVC) is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific. For more information about the company and its products, visit Invacare's website at www.invacare.com.
This press release contains forward-looking statements within the meaning of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those that describe future outcomes or expectations that are usually identified by words such as “will,” “should,” “could,” “plan,” “intend,” “expect,” “continue,” “forecast,” “believe,” and “anticipate” and include, for example, any statement made regarding the company's future results. Actual results may differ materially as a result of various risks and uncertainties, including regulatory proceedings or the company's failure to comply with regulatory requirements or receive regulatory clearance or approval for the company's products or operations; circumstances or developments that may make the company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current business initiatives; possible adverse effects on the company’s liquidity that may result from delays in the implementation or realization of benefits from its current business initiatives; exchange rate fluctuations; and those other risks and uncertainties expressed in the cautionary statements and risk factors in the company’s annual report on Form 10-K, quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission. The company may not be able to predict and may have little or no control over many factors or events that may influence its future results and, except as required by law, shall have no obligation to update any forward-looking statements.